ARCHITECT 8D06-31Recalls & reported problems
Abbott GmbH · ARCHITECT Syphilis TP Reagent Kit · Class 1
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 00380740117115), received between Oct 20, 2017 and Dec 12, 2023 — classified as 3 malfunctions.
The most frequently reported specific device problem is “False Negative Result” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- False Negative Result2
- False Positive Result1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
- No Code Available1
- No Known Impact Or Consequence To Patient1
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 12, 2023False Negative Result; False Negative Result
THE CUSTOMER OBSERVED A FALSE NONREACTIVE ARCHITECT SYPHILIS TP RESULT FOR ONE SAMPLE. THE FOLLOWING DATA WAS PROVIDED: SID (B)(6) : ARCHITECT (B)(6) RESULT WAS NONREACTIVE, TITER WAS >256, ARUP RESULT WAS REACTIVE FOR TROUBLESHOOTING PURPOSES ONLY, THE SAMPLE WAS SENT TO ANOTHER LABORATORY AND REPEATED ON ANOTHER ARCHITECT (B)(6) WHICH GENERATED NONREACTIVE RESULTS. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 18314130 ↗MalfunctionDec 27, 2019False Positive Result; False Positive Result
THE CUSTOMER OBSERVED A FALSE REACTIVE ARCHITECT (B)(6) TP RESULT AND WAS INQUIRING IF THE ASSAY HAS ANY CROSS REACTIVITY WITH RED CELL ANTIGENS. THE FOLLOWING DATA WAS PROVIDED FOR THE PATIENT IN QUESTION: INITIAL RESULT = 1.71 S/CO (REACTIVE), MHA TP = REACTIVE, RPR = NONREACTIVE. THE PATIENT IS POSITIVE FOR THE "C" ANTIGEN AND RECENTLY DELIVERED A BABY. THE NEWBORN BABY HAD A SPINAL TAP PROCEDURE TO RETRIEVE CEREBROSPINAL FLUID FOR (B)(6) TESTING: ARCHITECT (B)(6) = REACTIVE, RPR = NONREACTIVE, MHA TP = NONREACTIVE, VDRL = NONREACTIVE. THE SPINAL TAP WAS PERFORMED DUE TO THE FALSE REACTIVE ARCHITECT (B)(6) RESULTS ON THE MOTHER'S SAMPLE.
Patient problems: No Code Available
MAUDE report 9527284 ↗MalfunctionOct 20, 2017False Negative Result; False Negative Result
THE CUSTOMER REPORTED A FALSE NON-REACTIVE ARCHITECT SYPHILIS TP RESULT FOR ONE POSTPARTUM PATIENT THAT WAS PREVIOUSLY TREATED FOR (B)(6). SAMPLE ID (B)(6) GENERATED A NEGATIVE (0.14 S/CO) RESULT ON THE ARCHITECT ASSAY AND POSITIVE ON THE RPR ASSAY. THE CUSTOMER FURTHER INDICATED THE BABY WAS ALSO POSITIVE ON RPR. NO FURTHER PATIENT INFORMATION WAS PROVIDED. NO IMPACT TO PATIENT MANAGEMENT WAS REPORTED.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 6965649 ↗
Other SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED) devices
- CONTOUR® NEXT 7314Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)227 reports
- FastPack® IP SHBG FastPack® IP SHBG 30 ImmunoassayQualigen Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)2 recalls0 reports
- CONTOUR® NEXT 7377Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)95 reports
- ARCHITECT 7K62-25Abbott Ireland · SINGLE (SPECIFIED) ANALYTE CONTROLS (ASSAYED AND UNASSAYED)94 reports
- ARCHITECT 08K2812Abbott GmbH · Single (specified) analyte controls (assayed and unassayed)1 recall12 reports
- CONTOUR® NEXT 9697Ascensia Diabetes Care US Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)56 reports
- VITROS 6192257Ortho Clinical Diagnostics · Single (specified) analyte controls (assayed and unassayed)1 recall0 reports
- McKesson 5011Mckesson Medical-Surgical Inc. · Single (Specified) Analyte Controls (Assayed And Unassayed)1 recall0 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.